Compare CCOI & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCOI | TLRY |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.6M | 570.4M |
| IPO Year | 2002 | 2018 |
| Metric | CCOI | TLRY |
|---|---|---|
| Price | $9.31 | $4.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $29.11 | ★ $72.33 |
| AVG Volume (30 Days) | 1.8M | ★ 3.7M |
| Earning Date | 05-04-2026 | 04-01-2026 |
| Dividend Yield | ★ 0.34% | N/A |
| EPS Growth | 11.21 | ★ 55.69 |
| EPS | ★ 0.56 | N/A |
| Revenue | ★ $975,766,000.00 | N/A |
| Revenue This Year | $11.76 | $8.79 |
| Revenue Next Year | $6.09 | $19.98 |
| P/E Ratio | $17.04 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.00 | $0.77 |
| 52 Week High | $45.69 | $15.70 |
| Indicator | CCOI | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 48.04 |
| Support Level | $9.02 | $4.30 |
| Resistance Level | $11.47 | $4.91 |
| Average True Range (ATR) | 0.78 | 0.21 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 16.59 | 26.55 |
Cogent carries over one-fifth of the world's internet traffic on its network, providing high-capacity services to businesses. Cogent's netcentric customers, which contribute nearly half of total revenue, include internet service providers and content providers, to which Cogent provides internet transit service. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US. Cogent's corporate customers are in high-rise office buildings, where the firm provides two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking. Cogent's corporate customers are exclusively in North America and account for about 40% of the firm's revenue.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.